APA

Díaz-Beyá M., Brunet S., Nomdedéu J., Pratcorona M., Cordeiro A., Gallardo D., Escoda L., Tormo M., Heras I., Ribera J. M., Duarte R., de Llano M. P. Q., Bargay J., Sampol A., Nomdedeu M., Risueño R. M., Hoyos M., Sierra J., Monzo M., Navarro A. & Esteve J. (20160808). The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. : Oncotarget.

Chicago

Díaz-Beyá Marina, Brunet Salut, Nomdedéu Josep, Pratcorona Marta, Cordeiro Anna, Gallardo David, Escoda Lourdes, Tormo Mar, Heras Inmaculada, Ribera Josep Maria, Duarte Rafael, de Llano María Paz Queipo, Bargay Joan, Sampol Antonia, Nomdedeu Meritxell, Risueño Ruth M, Hoyos Montserrat, Sierra Jorge, Monzo Mariano, Navarro Alfons and Esteve Jordi. 20160808. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. : Oncotarget.

Harvard

Díaz-Beyá M., Brunet S., Nomdedéu J., Pratcorona M., Cordeiro A., Gallardo D., Escoda L., Tormo M., Heras I., Ribera J. M., Duarte R., de Llano M. P. Q., Bargay J., Sampol A., Nomdedeu M., Risueño R. M., Hoyos M., Sierra J., Monzo M., Navarro A. and Esteve J. (20160808). The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. : Oncotarget.

MLA

Díaz-Beyá Marina, Brunet Salut, Nomdedéu Josep, Pratcorona Marta, Cordeiro Anna, Gallardo David, Escoda Lourdes, Tormo Mar, Heras Inmaculada, Ribera Josep Maria, Duarte Rafael, de Llano María Paz Queipo, Bargay Joan, Sampol Antonia, Nomdedeu Meritxell, Risueño Ruth M, Hoyos Montserrat, Sierra Jorge, Monzo Mariano, Navarro Alfons and Esteve Jordi. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. : Oncotarget. 20160808.